StockWaves
  • Home
  • Global Markets
    Global MarketsShow More
    Australia's PM says easing of curbs on US beef not prompted by Trump
    Australia's PM says easing of curbs on US beef not prompted by Trump
    0 Min Read
    Development, buybacks and dividends galore – are NatWest shares the final word no-brainer purchase?
    Development, buybacks and dividends galore – are NatWest shares the final word no-brainer purchase?
    4 Min Read
    Ghislaine Maxwell Justice Division conferences
    Ghislaine Maxwell Justice Division conferences
    9 Min Read
    CoinShares Bitcoin ETF adjustments identify from CoinShares Valkyrie Bitcoin Fund
    CoinShares Bitcoin ETF adjustments identify from CoinShares Valkyrie Bitcoin Fund
    0 Min Read
    Listed below are 3 methods to consider Nvidia inventory
    Listed below are 3 methods to consider Nvidia inventory
    4 Min Read
  • Investment Strategies
    Investment StrategiesShow More
    A Full Information for First-Time Taxpayers
    A Full Information for First-Time Taxpayers
    12 Min Read
    After How Many Days Bonus Shares Can Be Bought?
    After How Many Days Bonus Shares Can Be Bought?
    8 Min Read
    The Weekly Wrap | Up, Up and Away. Not.
    The Weekly Wrap | Up, Up and Away. Not.
    24 Min Read
    India's most underrated funding asset
    India's most underrated funding asset
    0 Min Read
    Prime information and market movers this week: twenty fifth Jul’ 2025
    Prime information and market movers this week: twenty fifth Jul’ 2025
    2 Min Read
  • Market Analysis
    Market AnalysisShow More
    Cipla to Bajaj Finserv – Jay Thakkar suggests three shares to purchase or promote for short-term in F&O section
    Cipla to Bajaj Finserv – Jay Thakkar suggests three shares to purchase or promote for short-term in F&O section
    6 Min Read
    Gold worth rises 200% in six years. How costly it could grow to be in subsequent 5 years?
    Gold worth rises 200% in six years. How costly it could grow to be in subsequent 5 years?
    10 Min Read
    Kotak Mahindra Financial institution Q1 Outcomes: Internet revenue drops 7% to ₹3,282 crore. Test particulars
    Kotak Mahindra Financial institution Q1 Outcomes: Internet revenue drops 7% to ₹3,282 crore. Test particulars
    2 Min Read
    Nuvama sees 40% upside in THIS multibagger inventory. Do you have to purchase?
    Nuvama sees 40% upside in THIS multibagger inventory. Do you have to purchase?
    3 Min Read
    Kotak Mahindra Financial institution Q1 FY26 Outcomes: Snapshot
    Kotak Mahindra Financial institution Q1 FY26 Outcomes: Snapshot
    13 Min Read
  • Trading
    TradingShow More
    Exiled Iranian Prince Reza Pahlavi Claims 50,000 Defectors Have Joined His Motion To Topple Tehran Regime
    Exiled Iranian Prince Reza Pahlavi Claims 50,000 Defectors Have Joined His Motion To Topple Tehran Regime
    3 Min Read
    Scams, Misplaced Keys, and Forgotten Wallets: The Bitcoin Whisperer Who Brings Crypto Again
    Scams, Misplaced Keys, and Forgotten Wallets: The Bitcoin Whisperer Who Brings Crypto Again
    3 Min Read
    Benzinga Bulls And Bears: T-Cellular, LendingTree, Molina Healthcare — And Commerce Deal Optimism Boosts Markets Benzinga Bulls And Bears: T-Cellular, LendingTree, Molina Healthcare — And Commerce Deal Optimism Boosts Markets
    Benzinga Bulls And Bears: T-Cellular, LendingTree, Molina Healthcare — And Commerce Deal Optimism Boosts Markets Benzinga Bulls And Bears: T-Cellular, LendingTree, Molina Healthcare — And Commerce Deal Optimism Boosts Markets
    5 Min Read
    Senator Lummis Champions Bitcoin as Important: ‘Freedom Cash and Will Make Life Higher for Each American’ Senator Lummis Champions Bitcoin as Important: ‘Freedom Cash and Will Make Life Higher for Each American’
    Senator Lummis Champions Bitcoin as Important: ‘Freedom Cash and Will Make Life Higher for Each American’ Senator Lummis Champions Bitcoin as Important: ‘Freedom Cash and Will Make Life Higher for Each American’
    3 Min Read
    Marjorie Taylor Greene’s Berkshire Hathaway Funding Falters After She Purchased The Shares At April Lows — What If She Had Chosen Bitcoin As a substitute?
    Marjorie Taylor Greene’s Berkshire Hathaway Funding Falters After She Purchased The Shares At April Lows — What If She Had Chosen Bitcoin As a substitute?
    3 Min Read
Reading: Pharma inventory jumps 4% after $7 Million settlement with Humana, Centene, and Kaiser
Share
Font ResizerAa
StockWavesStockWaves
  • Home
  • Global Markets
  • Investment Strategies
  • Market Analysis
  • Trading
Search
  • Home
  • Global Markets
  • Investment Strategies
  • Market Analysis
  • Trading
Follow US
2024 © StockWaves.in. All Rights Reserved.
StockWaves > Financial News > Pharma inventory jumps 4% after $7 Million settlement with Humana, Centene, and Kaiser
Financial News

Pharma inventory jumps 4% after $7 Million settlement with Humana, Centene, and Kaiser

StockWaves By StockWaves Last updated: February 24, 2025 4 Min Read
Pharma inventory jumps 4% after  Million settlement with Humana, Centene, and Kaiser
SHARE


Contents
Share Value MotionFirm ReplaceAdditionally learn: Inventory below ₹20 in focus after receiving ₹11 Cr order from Increased Schooling Division DelhiMonetary HighlightsConcerning the FirmDisclaimer

The Pharma firm is in focus after it jumped 4.15 % following its a number of lawsuits settlement with three corporations for 7 Million US {Dollars} for 2 medication Zetia and Vytorin.

Share Value Motion

With a market capitalization of Rs. 37,670 Crore, the inventory of Glenmark Pharma Restricted opened on the identical worth as yesterday’s shut of Rs. 1300.80. After reporting the enterprise replace inventory jumped to a excessive of Rs. 1354.85 up 4.15 %.

Firm Replace

Glenmark and its subsidiary have been concerned in a number of antitrust and client safety lawsuits, together with a category motion in reference to generic Zetia, a drug used for the therapy of ldl cholesterol, and 4 lawsuits included claims associated to the Vytorin drug.

Lawsuits alleged that in 2010, Glenmark entered an anticompetitive settlement to settle patent infringement litigation involving a patent associated to ezetimibe (the lively ingredient in Zetia) with Schering Company and

MSP Singapore Firm LLC. In 2023, Glenmark settled with three plaintiff teams known as the Direct Purchaser Plaintiffs, the Retailer Plaintiffs, and the Finish-Payor Plaintiffs.

These 4 lawsuits, which included claims associated to each generic Zetia and Vytorin, have been subsequently remanded to the jurisdictions through which they have been initially filed. Glenmark determined to resolve the dispute and keep away from uncertainty they agreed to a settlement with Humana, Centene, and Kaiser for a complete of seven Million US {Dollars}. Glenmark additionally states that they deny each one of many allegations towards it.

Additionally learn: Inventory below ₹20 in focus after receiving ₹11 Cr order from Increased Schooling Division Delhi

Monetary Highlights

The corporate reported a 35.13 % YoY improve in income from operations to Rs. 2506.70 Crore in Q3FY24 to Rs. 3387.55 Crore in Q3FY25. On a QoQ foundation, the corporate reported a lower of 1.34 % in income from Rs. 3433.79 Crore within the earlier quarter.

Their Web revenue noticed a turnaround YoY from Rs. 449.58 Crore loss to Rs. 348.03 Crore revenue for a similar interval. On a QoQ foundation, the corporate reported a lower of 1.81 % in Web revenue from Rs. 354.48 Crore within the earlier quarter.

Pharma inventory jumps 4% after  Million settlement with Humana, Centene, and Kaiser

Concerning the Firm

Glenmark Prescribed drugs Restricted is a worldwide pharmaceutical firm headquartered in Mumbai, India, with a robust presence in a number of international locations. Established in 1977, the corporate has developed from a generic drug producer to a frontrunner in specialty and progressive medicines, specializing in therapeutic areas comparable to respiratory, dermatology, and oncology. 

With a number of analysis and improvement facilities and manufacturing amenities throughout continents, Glenmark is dedicated to advancing healthcare by cutting-edge analysis and strategic collaborations. Over time, it has launched varied novel therapies and biosimilars, reinforcing its place within the pharmaceutical business.

Written By Abhishek Das

Disclaimer

The views and funding suggestions expressed by funding consultants/broking homes/score companies on tradebrains.in are their very own, and never that of the web site or its administration. Investing in equities poses a threat of monetary losses. Traders should subsequently train due warning whereas investing or buying and selling in shares. Dailyraven Applied sciences or the creator are usually not chargeable for any losses brought about because of the choice based mostly on this text. Please seek the advice of your funding advisor earlier than investing.

Sign Up For Daily Newsletter

Be keep up! Get the latest breaking news delivered straight to your inbox.

By signing up, you agree to our Terms of Use and acknowledge the data practices in our Privacy Policy. You may unsubscribe at any time.
Share This Article
Facebook Twitter Copy Link Print
Previous Article Down 60% this month, is FTSE 250 inventory John Wooden Group value a glance? Down 60% this month, is FTSE 250 inventory John Wooden Group value a glance?
Next Article UP information: Hardoi trainer thrashes 10-year-old, breaks leg over flawed reply, tries to settle with ₹200 UP information: Hardoi trainer thrashes 10-year-old, breaks leg over flawed reply, tries to settle with ₹200
Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

FacebookLike
TwitterFollow
PinterestPin
InstagramFollow

Subscribe Now

Subscribe to our newsletter to get our newest articles instantly!

Most Popular
US girl lists what she loves and hates about residing in India: ‘I adore it, however…’
US girl lists what she loves and hates about residing in India: ‘I adore it, however…’
July 27, 2025
Valuations excessive, earnings weak — Markets could pause
Valuations excessive, earnings weak — Markets could pause
July 27, 2025
Australia's PM says easing of curbs on US beef not prompted by Trump
Australia's PM says easing of curbs on US beef not prompted by Trump
July 27, 2025
Bihar Meeting Polls: CM Nitish Kumar proclaims Rs 15,000 pension for journalists; spouses to get lifetime advantages
Bihar Meeting Polls: CM Nitish Kumar proclaims Rs 15,000 pension for journalists; spouses to get lifetime advantages
July 27, 2025
High 5 Most Invaluable Soccer Golf equipment within the World Proper Now – (2025 Rating)
High 5 Most Invaluable Soccer Golf equipment within the World Proper Now – (2025 Rating)
July 27, 2025

You Might Also Like

Valuations excessive, earnings weak — Markets could pause
Financial News

Paytm shares drop 2% after Vijay Shekhar Sharma forfeits 2.1 crore shares

2 Min Read
Shares in Focus: BHEL, Alembic Pharma, GAIL (India), and Others
Financial News

Shares in Focus: BHEL, Alembic Pharma, GAIL (India), and Others

5 Min Read
Valuations excessive, earnings weak — Markets could pause
Financial News

ICICI Prudential This autumn outcomes: PAT jumps 122% YoY to Rs 385 crore, Co declares ultimate dividend

3 Min Read
Property Costs Hovering in These 4 Gurugram Areas – Are You In But?
Financial News

Property Costs Hovering in These 4 Gurugram Areas – Are You In But?

7 Min Read

Always Stay Up to Date

Subscribe to our newsletter to get our newest articles instantly!

StockWaves

We provide tips, tricks, and advice for improving websites and doing better search.

Latest News

  • About Us
  • Contact Us
  • Privacy Policy
  • Terms Of Service

Resouce

  • Blockchain
  • Business
  • Economics
  • Financial News
  • Global Markets
  • Investment Strategies
  • Market Analysis
  • Trading

Trending

US girl lists what she loves and hates about residing in India: ‘I adore it, however…’
Valuations excessive, earnings weak — Markets could pause
Australia's PM says easing of curbs on US beef not prompted by Trump

2024 © StockWaves.in. All Rights Reserved.

Welcome Back!

Sign in to your account

Not a member? Sign Up